Ash Team
July 3, 2025
•
5 min read
We are thrilled to announce a strategic partnership between Ash and Impilo, two leaders in at-home healthcare solutions, to expand access to comprehensive health monitoring and testing across the U.S. This collaboration combines Ash’s customizable health testing capabilities with Impilo’s advanced logistics and data platform, creating a powerful, end-to-end offering designed to help healthcare organizations, digital health companies, and health plans close care gaps and improve outcomes at scale.
The partnership between Ash and Impilo seamlessly merges their distinct strengths to redefine at-home healthcare. Ash, a leading at-home health testing platform, excels in tailoring end-to-end testing solutions and effectively engaging patients to improve health outcomes. Impilo complements this with its expertise in virtual care operations, providing a plug-and-play platform for managing remote patient monitoring devices, logistics, and data integration.
This collaboration is vital for a comprehensive patient health journey. Ash contributes high-value health data and engagement strategies, while Impilo provides the operational backbone for device management and seamless care delivery. Together, their combined capabilities reduce administrative burden for clients and create a unified, scalable approach to at-home health monitoring and testing, ultimately driving better patient outcomes.
This partnership delivers a one-stop solution that significantly reduces administrative burden for our clients while providing a comprehensive suite of services.
Health Plans: This partnership enables plans to effectively close critical care gaps (e.g., A1C, colorectal, hypertension, blood pressure), improve adherence, reduce ED visits, and boost engagement in underserved populations. It also supports digital-first or hybrid models to drive retention and outcomes, and offers an alternative to onsite employer events for annual health checkups and biometric screenings.
Digital Health Companies: Virtual care programs in primary care, chronic disease, women’s health, and behavioral health increasingly require both patient biometrics and lab testing. This partnership offers a single, streamlined solution to manage the logistics of delivering and orchestrating both, providing the essential data needed for comprehensive patient care.
At-Risk Provider Groups/ACOs: A turnkey solution for delivering population screening and longitudinal monitoring from the home that gives access to test kits, RPM devices, and fulfillment services without the need to build out complex logistics infrastructure, reducing cost and aligning with value-based care models.
The Ash + Impilo partnership brings the clinic directly to the home. It offers a one-stop solution for health plans and digital health platforms to identify, diagnose, monitor, and engage members at home, leveraging clinical-grade at-home lab results, connected monitoring devices, and next-generation 3PL support—all fully integrated for scalability.
Key Benefits:
Example Use Cases:
By combining our strengths, Ash and Impilo are setting a new standard in healthcare, prioritizing access, impact, and real-world results. This collaboration ensures patients are better understood and receive the comprehensive care they deserve.
The partnership is now live and available to enterprise partners and healthcare organizations nationwide.
To learn more about how Ash and Impilo can enhance your healthcare programs, visit our websites: